Andreas Puschnik leads infectious disease drug development at Vir Biotechnology, leveraging his expertise from previous group leadership at CZ Biohub. He earned a PhD from Stanford, was a Fulbright scholar at UC Berkeley, and holds a BSc from TU München, combining advanced research and academic excellence in biomedical sciences.

‌